Abdelmoujoud Faris

7PUBLICATIONS
22CO-AUTHORS
Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 11, 2024
Computational 3D Modeling-Based Identification of Inhibitors Targeting Cysteine Covalent Bond Catalysts for JAK3 and CYP3A4 Enzymes in the Treatment of Rheumatoid Arthritis.

Abdelmoujoud Faris, Radwan Alnajjar, Jingjing Guo

|Dec 07, 2023
QSAR-driven screening uncovers and designs novel pyrimidine-4,6-diamine derivatives as potent JAK3 inhibitors.

Abdelmoujoud Faris, Ibrahim M Ibrahim, Radwan Alnajjar

|Oct 20, 2023
In silico computational drug discovery: a Monte Carlo approach for developing a novel JAK3 inhibitors.

Abdelmoujoud Faris, Ivana Cacciatore, Ibrahim M Ibrahim

|Aug 12, 2023
Computer-Aided Drug Design of Novel Derivatives of 2-Amino-7,9-dihydro-8H-purin-8-one as Potent Pan-Janus JAK3 Inhibitors.

Abdelmoujoud Faris, Ibrahim M Ibrahim, Omkulthom Al Kamaly

|Aug 04, 2023
High-throughput virtual screening of phenylpyrimidine derivatives as selective JAK3 antagonists using computational methods.

Abdelmoujoud Faris, Ibrahim M Ibrahim, Hanine Hadni

|Jun 20, 2023
In silico discovery of potent and selective Janus kinase 3 (JAK3) inhibitors through 3D-QSAR, covalent docking, ADMET analysis, molecular dynamics simulations, and binding free energy of pyrazolopyrimidine derivatives.

Abdelmoujoud Faris, Hanine Hadni, Ibrahim M Ibrahim

Pageof 2

Frequent Collaborators

4 joint publications

Kamal Tabti

3 joint publications

Ibrahim M Ibrahim

2 joint publications

Radwan Alnajjar

2 joint publications

Mohammed H Al Mughram